Cutler Group LP Novo Cure LTD Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Jul 18, 2023	SELL	$40.29 - $82.51 $32,232 - $66,008	-800 Reduced 12.9%	5,400 $49,000
Q1 2023 May 01, 2023	BUY	$56.44 - $118.81 $141,100 - $297,025	2,500 Added 67.57%	6,200 $173,000
Q4 2022 Feb 07, 2023	SELL	$63.98 - $85.37 $12,796 - $17,074	-200 Reduced 5.13%	3,700 $277,000
Q3 2022 Oct 25, 2022	BUY	$67.99 - $89.57 $33,995 - $44,785	500 Added 14.71%	3,900 $251,000
Q2 2022 Aug 04, 2022	SELL	$56.6 - $89.9 $237,720 - $377,580	-4,200 Reduced 55.26%	3,400 $277,000
Q1 2022 Apr 14, 2022	BUY	$60.15 - $84.52 $168,420 - $236,656	2,800 Added 58.33%	7,600 $275,000
Q3 2021 Oct 26, 2021	BUY	$116.17 - $194.55 $441,446 - $739,290	3,800 Added 380.0%	4,800 $198,000
Q2 2021 Jul 19, 2021	BUY	$130.4 - $225.58 $130,400 - $225,580	1,000 New	1,000 $4,000
Q1 2018 May 11, 2018	SELL	$19.3 - $23.65 $19,300 - $23,650	-1,000 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$16.3 - $21.9 $14,670 - $19,710	-900 Reduced 47.37%	1,000 $0
Q3 2017 Oct 17, 2017	BUY	$18.05 - $21.75 $34,295 - $41,325	1,900	1,900 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.